Position in BMY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,055,771
+$15,563 QoQ
Shares Held
18,323
+6.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#1,134
of 2,506 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 16%
Shared 0%
None 84%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hexagon Capital Partners LLC holds $11,707,728 across 11 Drug Manufacturers - General names. BMY ranks #6 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
8,314 | $2,092,134 | |
| 2 | MRK |
Merck & Co., Inc.
|
13,420 | $1,724,470 | |
| 3 | LLY |
ELI LILLY & Co
|
1,184 | $1,420,125 | |
| 4 | PFE |
Pfizer Inc
|
54,852 | $1,320,836 | |
| 5 | JNJ |
Johnson & Johnson
|
5,167 | $1,312,262 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
18,323 | $1,055,771 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,901 | $871,872 | |
| 8 | NVS |
Novartis AG
|
3,990 | $625,312 |
All Filings in BMY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,055,771 | 18,323 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,040,208 | 17,151 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $959,322 | 17,785 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $801,787 | 17,778 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $810,491 | 17,509 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,088,122 | 17,841 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $977,017 | 17,274 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $817,957 | 15,809 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $487,105 | 11,729 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $850,163 | 15,677 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $720,443 | 14,041 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $585,391 | 10,086 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $588,276 | 9,199 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $603,551 | 8,708 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $619,201 | 8,606 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $688,435 | 9,684 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $593,516 | 7,708 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $596,655 | 8,170 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $545,375 | 8,747 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $399,752 | 6,756 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $433,728 | 6,491 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $369,310 | 5,850 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $344,638 | 5,556 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $310,252 | 5,146 | Shares | Sole | 2020-11-10 | |
| No filing history on record for this holder in this stock. | ||||||